Stimulation of the Antigen Receptor Complex Leads to Transcriptional Activation of the c-myc Gene in Normal Human T Cells

  • T. Lindsten
  • C. H. June
  • C. B. Thompson
Conference paper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 141)


The expression of the cellular proto-oncogene c-myc has been implicated in growth regulation of both normal and neoplastic cells (for review see Eisenman and Thompson 1986). Quiescent lymphocytes have been shown to express low levels of both c-myc mRNA and protein (Smeland et al. 1987). Stimulation of lymphocytes with mitogens results in the rapid accumulation of c-myc mRNA to levels 10–20 times above background within 2 hours following stimulation (Kelly et al. 1983). Thereafter, c-myc mRNA and protein continue to be expressed throughout the proliferative response of mitogen-activated cells (Hann et al. 1985, Thompson et al. 1985, Rabbitts et al. 1985). The ability of mitogen-activated cells to enter S phase of the cell cycle can be blocked by anti-sense myc oligonucleotides (Heikkila et al. 1987). Constitutive expression of c-myc in murine 3T3 cells has been shown to lead to partial growth factor independence of cell proliferation (Armelin et al. 1984). Finally, agents such as γ-interferon which arrest cell proliferation in vitro are associated with downregulation of c-myc gene expression (Einat et al. 1985). Taken together, these results suggest that the c-myc proto-oncogene may encode a regulatory nuclear protein required for the proliferation of lymphoid cells.


Lymphoma Leukemia Bromide Interferon Half Life 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aritielin HA, Armelin MCS, Kelly K, Stewart T, Leder P, Cochran BH, Stiles CD (1984) Functional role of c-myc in mitogenic response to platelet-derived growth factor. Nature 310:655–660CrossRefGoogle Scholar
  2. Bentley DL, Groudine M (1986) A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature (London) 321:702–706PubMedCrossRefGoogle Scholar
  3. Bentley DL, Groudine M (1986) Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas. Mol. Cell. Biol. 6:3481–3489PubMedGoogle Scholar
  4. Blanchard JM, Piechaczyk M, Dani C, Chambard JC, Franchi A, Pouyssegur J, Jeanteur P (1985) c-myc gene is transcribed at high rate in GO-arrested fibroblasts and is posttranscriptionally regulated in response to growth factors. Nature (London) 317:443–445PubMedCrossRefGoogle Scholar
  5. Buckler AJ, Rothstein TL, Sonenshein GE (1988) Two-step stimulation of B lymphocytes to enter DNA synthesis: Synergy between antiimmunoglobulin antibody and cytochalasin on expression of c-myc and a G1-specific gene. Mol. Cell. Biol. 8:1371–1375PubMedGoogle Scholar
  6. Cesarman E, Dalla-Favera R, Bentley D, Groudine M (1987) Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science 238:1272–1274PubMedCrossRefGoogle Scholar
  7. Dani C, Blanchard JM, Piechaczyk M, El Sabouty S, Marty L, Jeanteur P (1984) Extreme instability of myc mRNA in normal and transformed human cells. Proc. Natl. Acad. Sci. USA 81:7046–7050PubMedCrossRefGoogle Scholar
  8. Dyson PJ, Rabbitts TH (1985) Chromatin structure around the c-myc in Burkitt lymphomas with upstream and downstream translocation points. Proc. Natl. Acad. Sci. USA 82:1984–1988PubMedCrossRefGoogle Scholar
  9. Eick D, Bornkamm GW (1986) Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. Nucleic Acids Res. 14:8331–8346PubMedCrossRefGoogle Scholar
  10. Eick D, Piechaczyk M, Henglein B, Blanchard JM, Traub B, Kofler E, Wiest S, Lenoir GM, Bornkamm GW (1985) Aberrant c-myc RNAs of Burkitt’s lymphoma cells have longer half-lives. EMBO J. 4:3717–3725PubMedGoogle Scholar
  11. Einat M, Resnitzky D, Kimchi A (1985) Close link between reduction of c-myc expression by interferon and G0/G1 arrest. Nature 313:597–600PubMedCrossRefGoogle Scholar
  12. Eisenman RN, Thompson CB (1986) Oncogenes with potential nuclear function: myc, myb, and fos. Cancer Surveys 5:309–327.PubMedGoogle Scholar
  13. Erikson J, Finger L, Sun L, Ar-Rushdi A, Nishikura K, Minowada J, Finan J, Emanuel BS, Nowell PC, Croce CM (1986) Deregulation of c-myc by translocation of the α-locus of the T-cell receptor in T-cell leukemias. Science 232:884–886PubMedCrossRefGoogle Scholar
  14. Hann SR, Thompson CB, Eisenman RN (1985) c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 314:366–369PubMedCrossRefGoogle Scholar
  15. Heikkila R, Schwab G, Wickstrom E, Loke SL, Pluznik DH, Watt R, Neckers LM (1987) A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress form G0 to G1. Nature 328:445–449PubMedCrossRefGoogle Scholar
  16. Jones TR, Cole MD (1987) Rapid cytoplasmic turnover of c-myc mRNA: Requirement of the 3’ untranslated sequences. Mol. Cell. Biol. 7:4513–4521PubMedGoogle Scholar
  17. June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB (1987) T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472–4481PubMedGoogle Scholar
  18. Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610PubMedCrossRefGoogle Scholar
  19. Ledbetter JA, Gentry LE, June CH, Rabinovitch PS, Purchio AF 1987 Stimulation of T cells through the CD3/T-cell receptor complex: Role of cytoplasmic calcium, protein kinase C translocation, and phosphorylation of pp60c-src in the activation pathway. Mol. Cell. Biol. 7:650PubMedGoogle Scholar
  20. Nepveu A, Marcu KB (1986) Intragenic pausing and anti-sense transcription within the murine c-myc locus. EMBO J. 5:2859–2865PubMedGoogle Scholar
  21. Rabbitts PH, Watson JV, Lamond A, Forster A, Stinson MA, Evan G, Fischer W, Atherton E, Sheppard R, Rabbitts TH (1985) Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J. 4:2009–2015PubMedGoogle Scholar
  22. Saito H, Hayday AC, Wiman K, Hayward WS, Tonegawa S (1983) Activation of the c-myc gene by translocation: A model for translational control. Proc. Natl. Acad. Sci. USA 80:7476–7480PubMedCrossRefGoogle Scholar
  23. Smeland E, Godai T, Ruud E, Beiske K, Funderud S, Clark EA, Pfeifer-Ohlsson S, Ohlsson R (1985) The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate. Proc. Natl. Acad. Sci. USA 82:6255–6259.PubMedCrossRefGoogle Scholar
  24. Smeland EB, Beiske K, Ek B, Watt R, Pfeifer-Ohlsson S, Blomhoff HK, Godal T, Ohlsson R (1987) Regulation of c-myc transcription and protein expression during activation of normal human B cells. Exp. Cell Res. 172:101–109PubMedCrossRefGoogle Scholar
  25. Thompson CB, Challoner PB, Neiman PE, Groudine M 1985 Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature 314:363–366PubMedCrossRefGoogle Scholar
  26. Truneh A, Albert F, Golstein P, Schmitt-Verhulst A (1985) Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313:318–320PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1988

Authors and Affiliations

  • T. Lindsten
    • 1
  • C. H. June
    • 2
  • C. B. Thompson
    • 1
  1. 1.Howard Hughes Medical Institute and Departments of Medicine and Microbiology/ImmunologyUniversity of MichiganAnn ArborUSA
  2. 2.Naval Medical Research InstituteBethesdaUSA

Personalised recommendations